List of Excipients in API saquinavir mesylate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing saquinavir mesylate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genentech Inc | INVIRASE | saquinavir mesylate | 0004-0244 | CELLULOSE, MICROCRYSTALLINE | |
| Genentech Inc | INVIRASE | saquinavir mesylate | 0004-0244 | CROSCARMELLOSE SODIUM | |
| Genentech Inc | INVIRASE | saquinavir mesylate | 0004-0244 | FERRIC OXIDE RED | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for saquinavir mesylate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
saquinavir mesylate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
saquinavir mesylate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
saquinavir mesylate drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
saquinavir mesylate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
saquinavir mesylate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
saquinavir mesylate drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
saquinavir mesylate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
saquinavir mesylate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
saquinavir mesylate drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
saquinavir mesylate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
saquinavir mesylate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
saquinavir mesylate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | saquinavir mesylate | 0004-0244 |
| State of Florida DOH Central Pharmacy | saquinavir mesylate | 53808-0674 |
| >Company | >Ingredient | >NDC |
saquinavir mesylate drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
